Aminoglycosides.

Slides:



Advertisements
Similar presentations
TUBERCULOSIS Pulmonary TB.
Advertisements

All the following are antibiotics used for gram –ve bacteria.
Training for junior doctors and pharmacists
Anti-tuberculous drugs. Mycobacteria Slow-growing bacillusDormant forms in macrophages.
AMINOGLYCOSIDES Streptomycin* Gentamicin* Tobramycin* Amikacin Kanamycin Neomycin(topical) * most commonly used Antibacterial Spectrum Bactericidal ( exclusive.
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms. ANTIBIOTICS Chemical.
PHL 424 Antimicrobials 6 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Aminoglycosides Mark Johnson, Pharm.D., BCPS
Drugs acting on bacterial protein biosynthesis
Non-pharmacologic Elevate the affected area to facilitate gravity drainage of edema and inflammatory substances – Patients with edema may benefit from.
Antibacterial Inhibitors of Cell Wall Synthesis –Very high therapeutic index Low toxicity with high effectiveness β- lactam Drugs –Inhibit peptidoglycan.
Chapter 37 Aminoglycosides
1 Inhibitors of Protein Synthesis Bacterial cells are 50% protein by dry weight –Inhibition of protein synthesis leads to cessation of growth or cell death.
Chapter 40 Aminoglycosides and Polymyxins Department of pharmacology Liu xiaokang( 刘小康) 2010,3.
AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.
Aminoglycosides All aminoglycosides are produced by soil actinomycetes. Obtained from the species of – Streptomyces (suffix mycin) – and Micromonospora.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Chemotherapy of Tuberculosis By Prof. Azza El-Medany.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 86 Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis.
2. Antibiotics - Aminoglycosides Pharmacognosy IV PHG 423 Dr/ Abdulaziz Saeedan Pharmacy College 1.
4 th Lecture By Abdelkader Ashour, Ph.D. Phone: DENS 521 Clinical Dental Therapeutics.
1 Drugs that Inhibit Cell wall synthesis Beta-lactams –Penicillin family –Cephalosporin family –Carbapenems and Monobactams –Β-lactamase inhibitors Vancomycin.
INHIBITOR of BACTERIAL PROTEIN SYNTHESIS. BACTERIAL PROTEIN SYNTHESIS The selectivity for bacterial protein synthesis is caused by differences in the.
Topical Antibiotics.
Dr. Laila M. Matalqah Ph.D. Pharmacology
(Doxycycline and Minocycline)
PRINCIPLES OF ANTIBIOTIC THERAPY
Among the many antibiotics isolated from that genus, several are compounds closely related in structure to streptomycin. Six of them kanamycin, neomycin,
Dr. Abdulaziz Bin Saeedan Department of Pharmacology College of Pharmacy MACROLIDES ANTIBIOTICS.
PROTEIN SYNTHESIS INHIBITORS THEY WORK BY TARGETING BACTERIAL RIBOSOMES AMINOGLYCOSIDES MACROLIDES TETRACYCLINES SPECTINOMYCIN.
Antimycobacterial Drugs September Mycobacteria Mycobacteria are intrinsically resistant to most antibiotics. Because they grow slowly compared with.
Aminoglycosides Antibiotics Dr. yasodha krishna janapati Associate Professor Dept. of Pharmaceutical Chemistry, College of Health Sciences (CHS), Ayder Campus, Mekelle University, Mekelle, ETHIOPIA Introduction: Aminoglycos
6th lecture in Antibiotics Other Cell Wall Inhibitors rather than Beta –Lactam Antibiotics (VANCOMYCIN , CYCLOSERINE.
Antibiotics By Alaina Darby.
Protein Synthesis Inhibitors
Drugs used in Meningitis Prof. M. Alhumayyd
AMINOGLYCOSIDES.
Antimicrobials acting on ribosome
The aminoglycoside antibiotics
Protein Synthesis Inhibitors
Miscellaneous Antibiotics
4. Antibiotics - Polymyxins (Polypeptides)
Natural antibiotics III
Lecture 1 Antimicrobial drugs.
By :Lecturer Nabeel Ahmed Al anbagi
Drugs /Agents Inhibitors of cell wall synthesis
Inhibitors of Protein Synthesis
CHEMOTHERAPY ANTIBIOTICS Chemical substances produced by microorganisms and have the capacity to inhibit or destroy other organisms . CHEMOTHERAPEUTIC.
Cephalosporin and Other Cell Wall Synthesis Inhibitors
Course Coordinator Jamaluddin Shaikh, Ph.D.
6th lecture in Antibiotics for biotechnology Other Cell Wall Inhibitors rather than Beta –Lactam Antibiotics (VANCOMYCIN.
Drug Treatment of Tuberculosis
Antituberculous Agents
Surgical Infection Society Resident Corner
by Dr.Sawsan Sajid & Dr. Ibtesam G.Auda
Cephalosporin and Cell Wall Synthesis Inhibitors
Drugs that Inhibit Cell wall synthesis
Aminoglycosides.
Course Coordinator Jamaluddin Shaikh, Ph.D.
Drug Resistance Bacteria are considered resistant to an antibiotic if the maximal level of that antibiotic that can be tolerated by the host does not halt.
Course Coordinator Jamaluddin Shaikh, Ph.D.
Broad-spectrum antibiotics
Cephalosporin and Cell Wall Synthesis Inhibitors
Chapter 38 Aminoglycosides
Other β-lactam A. Carbapenems:
Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis
2- Tetracyclines Classification
ANTIBIOTICS They are divided into four categories based on their bacteriostatic or bactericidal effect(mode of action) on various structures and macromolecules.
Principles of Antimicrobial Therapy
Presentation transcript:

Aminoglycosides

Aminoglycosides Streptomycin Neomycin Kanamycin Amikacin Gentamycin Tobramycin Sisomicin Netilmicin Are used for gram-negative bacteria in bacteremia or sepsis In combination with vancomycin or a penicillin for the treatment of endocarditis In tuberculosis treatment

Aminoglycosides Streptomycin is the prototype of this group. Gentamycin, tobramycin and amikacin are most widely used aminoglycosides at present. Neomycin and kanamycin are largely limited to topical use. Aminoglycosides show synergy when combined with beta-lactams or vancomycin. Aminoglycosides may complex w/ beta-lactams and inactivate. Therefore, they should not be mixed together for administration.

Mechanism of Action Binds specifically to 30 S ribosomal subunit. Protein synthesis is inhibited by aminoglycosides in at least three ways. Interfere the initiation complex of peptide formation. Induce misreading of mRNA results in systhesis of nonfunction or toxic protein. Break up of polysomes into non functional monosomes. Bacterial protein synthesis is irreversibly inhibited and bacteria dies.

Protein synthesis is inhibited by aminoglycosides in at least three ways.

Structure of streptomycin.

Structures of important aminoglycoside antibiotics.

Aminoglycosides Pharmacokinetics Absorption from GIS is poor. IM or IV route is prefered. Distribution in the body is poor. Excreted by kidneys, thus dose should be reduced in renal failure.

Aminoglycosides Adverse effects All are ototoxic and nefrotoxic. Especially when therapy is longer at high doses. Neomycin, kanamycin and amikacin are the most ototoxic agents in the group. Neomycin, tobramycin and gentamycin are the most nephrotoxic agents in the group. Streptomycin and gentamycin are vestibulotoxic (vertigo, ataxia, lost of balance). Curare-like effect at high doses.

Aminoglycosides Clinical Use Mostly used against gram-negative enteric bacteria and suspicion of sepsis, Enterecoccal, staphyloccal and streptococcal endocarditis in combination with a beta-lactam antibiotic.

Aminoglycosides Streptomycin Isolated from streptomyces griseus. Resistance has emerged in most species severely limiting its use today. Mycobacterial infections Is mainly used as the second line agent for the treatment of tuberculosis. The dosage is 0,5-1 g /day IM or IV. It should be used in combination with other anti tuberculosis drugs in order to prevent the resistance development. Nontuberculosis infections. In plague, tularemia and brucellosis, streptomycin is given IM in combination with an oral tetracyclin.

Aminoglycosides Streptomycin continued. Adverse reactions Hypersensitivity (fever, skin rash) Pain at the injection site Disturbance of the vestibular function (vertigo, loss of balance) If used in pregnancy, can cause deafness therefore contrindicated in pregnancy.

Aminoglycosides Gentamycin Isolated from Micromonospora purpurea. Effective against both gram-positive and gram-negative organisms. Active on the following bacteria alone or in combination w/ beta-lactams: peudomonas, proteus, enterobacter, klebsiella, serratia, stenotrophomonas Like all aminoglycosides no activity against anaerobes.

Aminoglycosides Gentamycin continued At present, gentamycin is employed mainly in severe infections (eg. Sepsis, pneumonia) caused by gram-negative bacteria that are likely to be resistant to other drugs. Is given intravenously. Should not be used as a single agent to treat staphylococcal infections. Because resistance develops rapidly. Renal functions should be monitored if administered more than few days. Ointments, creams or solutions are used for topical treatment of infected burns, wounds, skin lesions and prevention of catheter infections.

Aminoglycosides Amikacin Tobramycin Semisynthetic derivative of kanamycin. Less toxic than kanamycin. Strains of multidrug resistance Mycobacterium tuberculosis are usually susceptible to amikacin. Nefrotoxic and ototoxic. Tobramycin Similar to gentamycin.

Aminoglycosides Netilmisin Neomycin and Kanamycin Similar to gentamycin and tobramycin. Neomycin and Kanamycin Too toxic for parenteral use. Mainly used for bowel preperation for surgery.